Eredeti közlemények Kumulatív impakt faktor: Független hivatkozás: 3128

DR. BALLA JÓZSEF TUDOMÁNYOS PUBLIKÁCIÓI 2008. december Eredeti közlemények Kumulatív impakt faktor: 266.473 Független hivatkozás: 3128 1. Olah VA, Balla G, Balla J, Szabolcs A and Karmazsin L: An in vitro study of the hyroxyl scavenger effect of Cavinton. Acta Paediatr Hung, (1990) 30:309-316 2. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton J and Vercellotti GM: Ferritin: A cytoprotective antioxidant strategem of endothelium. J Biol Chem, (1992) 267:18148-18153 Impakt faktor: 7,258 3. Balla J, Jacob HS, Balla G, Jacob HS, Nath K and Vercellotti GM: Endothelial cell heme oxygenase and ferritin induction by heme proteins: A possible mechanism limiting shock damage. Trans Assoc Am Physicians, (1992) 105:1-6 4. Nath K, Balla G,Vercellotti GM, Balla J, Jacob HS, Levitt MD and Rosenberg M: Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest, (1992) 90:267-270 Impakt faktor: 14,118 5. Bok RA, Jacob HS, Balla J, Juckett M, Shatos MA and Vercellotti GM. Herpes simplex virus decreases endothelial cell plasminogen activator inhibitor. Thrombosis and Haemostasis, (1993) 69:253-258 Impakt faktor: 4,910 6. Balla J, Jacob HS, Balla G, Nath K, Eaton JW and Vercellotti GM: Endothelial-cell heme uptake from heme proteins: Induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA, (1993) 90:9285-9289 Impakt faktor: 10,896 7. Balla J, Belcher JD, Balla G, Jacob HS and Vercellotti GM: Oxidized lowdensity lipoprotein and endothelium: Oral vitamin E supplementation prevents oxidized low-density lipoprotein-mediated vascular injury. Trans Assoc Am Physicians, (1993) 106:128-133 8. Belcher JD, Balla J, Balla G, Jacobs D, Gross M, Jacob HS and Vercellotti GM: Vitamin E, LDL and endothelium: Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro. Arteriosclerosis and Thrombosis, (1993) 13:1779-1789 Impakt faktor: 5,816 9. Cermak J, Key NS, Bach RR, Balla J, Jacob HS and Vercellotti GM: C- reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood, (1993) 82:513-520 1

Impakt faktor: 9,273 10. Cermak J, Balla J, Jacob HS, Balla G, Enright H, Nath K and Vercellotti GM: Tumor cell heme uptake induces ferritin synthesis resulting in altered oxidant sensitivity: Possible role in chemotherapy efficacy. Cancer Research, (1993) 53:5308-5313 Impakt faktor: 8,302 11. Balla J, Balla G, Leövey A, Jacob HS, Vercellotti GM and Nath K: Heme Oxygenase and Ferritin Induction in Kidney and Endothelium to Prevent Oxidant Damage. Internal Medicine, (1994) 12:225-228 12. Vercellotti GM, Balla G, Balla J, Nath K, Eaton JW and Jacob HS: Heme and the vasculature: an oxidative hazard that induces antioxidant defenses in the endothelium. Artif Cells Blood Substit Immobil Biotechnol, (1994) 22:207-213 Impakt faktor: 0,636 Az utóbbi 10 évben megjelent 13. Balla J, Nath K, Balla G, Juckett MB, Jacob HS and Vercellotti GM: Endothelial cell heme oxygenase and ferritin induction in rat lung by hemoglobin in vivo. Am J Physiol, (1995) 268:L321-L327 Impakt faktor: 3,660 14. Nath K, Balla J, Croatt AJ and Vercelotti GM: Heme protein-mediated renal injury: A protective role for 21-aminosteroids in vitro and in vivo. Kidney Int, (1995) 47:592-602 Impakt faktor: 4,815 15. Juckett MB, Balla J, Balla G, Jessurun J, Jacob HS and Vercellotti GM: Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am J Pathol, (1995) 147:783-789 Impakt faktor: 7,103 16. Agarwal A, Balla J, Alam J, Croatt AJ, Nath K: Induction of heme oxygenase in toxic renal injury: A protective role in cisplatin nephrotoxicity in the rat. Kidney International, (1995) 48:1298-1307 Impakt faktor: 4,815 17. Balla J, Agarwal A, Balla G, Croatt A, Vercellotti GM and Nath K: Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am J Physiol, (1996) 271:F814-F823 Impakt faktor: 4,523 18. Juckett MB, Weber M, Balla J, Jacob HS and Vercellotti GM: Nitric oxide donors modulate ferritin and protect endothelium from oxidant injury. Free Radical Biology & Medicine, (1996) 20:63-73 Impakt faktor: 5,082 2

19. Ujhelyi L, Balla J, Muszbek L, Kakuk G, Belcher J, Jacob H, Vercellotti G, Balla G: A Microassay to assess the oxidative resistance of low-density lipoproteins. Clin Chem, (1998) 44:1762-1764 Impakt faktor: 4,371 20. Szegedi A, Jeney V, Dobolyi A, Balla J, Hunyadi J, Balla G: Humán endothel sejtek és keratinocyták oxidatív károsító hatásokkal szemben mutatott érzékenységének vizsgálata és összehasonlítása. B_rgyógyászati és Venerológiai Szemle, (1999) 5:201-204 21. Kakuk Gy, Balla J, Kárpáti I, Mátyus J, Újhelyi L, Varga Zs, Ben T, Seres I: A karbamilált hemoglobin vizsgálata a krónikus veseelégtelenség predialízis és dialízis stádiumában. Hypertonia és Nephrologia, (1999) 3:41-44 22. Kárpáti I, Lenkey Á, Mátyus J, Újhelyi L, Balla J, Varga Zs, Paragh Gy, Kakuk Gy: A béta-2-mikroglobulin hemodialízissel történ_ eliminációja és a kializáló membrán biokompatibilitása. Magyar Belorvosi Archivum, (1999) 52:231-235 23. Mátyus J, Kárpáti I, Ujhelyi L, Balla J, Ben T, Karányi Zs, Kakuk Gy: A hemodialízis-program fejl_dése és eredményei Debrecenben 1971-1996 között. Magyar Belorvosi Archivum, (1999) 52:237-242 24. Varga Zs, Kárpáti I, Mátyus J, Balla J, Paragh Gy, Seres I, Kakuk Gy: A plazmalipidek, és zsírsavak potenciális szerepe a neutrophilek fokozott oxidációs robbanásában krónikus vesebetegek esetében. Magyar Belorvosi Archivum, (1999) 52:249-253 25. Ujhelyi L, Balla G, Muszbek L, Kakuk G, Jeney V, Jacob H, Vercellotti M, Balla J: Új klinikai kémiai módszer a low-density lipoprotein oxidativ rezisztenciájának mérésére: alkalmazása hemodializált, végstádiumú veseelégtelenségben szenved_ betegeknél. Magyar Belorvosi Archivum, (1999) 52:243-247 26. Balla J, Balla G, Jeney V, Kakuk G, Jacob HS and Vercellotti GM: Ferriporphyrins and endothelium: a 2-edged sword promotion of oxidation and induction of cytoprotectants. Blood, (2000) 95:3442-3450 Impakt faktor: 9,273 27. Mátyus J, Király T, Kárpáti I, Ujhelyi L, Balla J, Paragh Gy, Kakuk Gy: Fibrát okozta súlyos rhabdomyolysis idült veseelégtelen betegekben. Magyar Belorvosi Archivum, (2001) 54:31-34 28. Balla J: Az oxydativ stress szerepe a glomerularis károsodásban. Magyar Orvos, (2001) 11:29 29. Sato K, Balla J, Smith N, Brouard S, Otterbein L, Lin Y, Csizmadia E, Anrather J, Sevigny J, Robson SC, Vercellotti GM, Choi AM, Bach FH and Soared MP: Carbon monoxide (CO) generated by heme oxygenase-1 can prevent xenograft rejection. J. Immunol, (2001) 166:4185-4194 Impakt faktor: 7,065 3

30. Galli F, Varga Z, Balla J, Ferraro B, Canestrari F, Floridi A, Kakuk G and Buoncristiani U: Vitamin E, lipid profile and peroxidation in hemodialysis patients. Kidney Int, (2001) 59:S148-S154 Impakt faktor: 4,815 31. Bereczki D, Balla G, Csiba L, Jeney V, Valikovics A, Magyar T and Balla J: A possible role of decreased oxidative resistance of low-density lipoproteins in the early formation of carotid atherosclerosis. Medical Hypotheses, (2001) 56:694-696 Impakt faktor: 0,745 32. Kovács T, Páll D, Abafalvi Zs, Karányi Zs, Wórum F, Mátyus J, Kárpáti I, Balla J, Ujhelyi L, Kakuk Gy: Akut toxikológiai eseteink klinikánk tízéves beteganyagában. Orvosi Hetilap, (2002) 143:71-76 33. Balla J, Jeney V, Yachie A, Varga Z, Vercellotti GM, Eaton JW, Balla G: Pro-oxidant and cytotoxic effects of circulating heme. Blood, (2002) 100:879-887 Impakt faktor: 9,273 34. Kárpáti I, Balla J, Sz_ke G, Bereczky Zs, Páll D, Ben T, Toma K, Katona E, Mohácsi A, Paragh Gy, Varga Zs, Kakuk Gy, Muszbek L: A hyperhomocysteinaemia gyakorisága, folsavpótlásban részesül_ hemodializált betegekben. Orvosi Hetilap, (2002) 143:1635-1640 35. Szabó Z, Kakuk G, Fülöp T, Mátyus J, Balla J, Kárpáti I, Juhász A, Kun Cs, Karányi Z, L_rincz I: Effects of haemodialysis on maximum P wave duration and P wave dispersion. Nephrol Dial Transplant, (2002) 12:1634-1638 Impakt faktor: 2.432 36. Balla J: A vasanyagcsere aktuális kérdései: Hypertonia és Nephrologia, (2002) 6:48-50 37. Mátyus J, Kiss I, Balla J: A renális anémia vizsgálata és kezelése krónikus veseelégtelenségben. ADU, (2002) 38. Mátyus j, Balla J, Paragh Gy: Lipidzavarok kezelése idült veseelégtelenségben. ADU, (2002) 39. Magyar TM, Szikszai Z, Balla J, Valikovics A, Kappelmayer J, Imre S, Balla G, Viktória J, Csiba L, Bereczki D: Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers Stroke, (2003) 34:58-63 Impakt faktor: 5,330 40. Balla J, Vercellotti GM, Nath K, Yachie A, Nagy E, Eaton J, JW, Balla G: Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transplant, (2003) 18(Suppl5):8-12 Impakt faktor: 2.432 41. Bereczki D, Nagy E, Pál A, Magyar M, Balla J: Should soluble CD40 ligand be measured from serum or plasma samples? Arterioscler Thromb Vasc Biol, (2003) 23:1129-1130 Impakt faktor: 5.816 4

42. Szabó Z, Kakuk Gy, Fülöp T, Mátyus J, Balla J, Kárpáti I, Juhász A, Kun Cs, Zemlényi G, Karányi Zs, L_rincz I: Pitvari arrhythmia hajlam vizsgálata hemodialízis alatt és után. Magyar Belorvosi Archivum, (2003) 56:23-27 43. Balla J, Vercellotti GM, Nath K, Yachie A, Nagy E, Eaton JW, Balla G: Haem, haem oxygenase and ferritin in vascular endothelial cell injury. Nephrol Dial Transplant, (2003) 18(Suppl5):8-12 Impakt faktor: 2.432 44. Zrinyi M, Juhasz M, Balla J, Katona E, Ben T, Kakuk G, Pall D: Dietary self-efficacy: determinant of compliance behaviours and biochemical outcomes in haemodialysis patients. Nephrol Dial Transplant, (2003) 18:1869-1873 Impakt faktor: 2.432 45. Bak I, Szendrei L, Turoczi T, Papp G, Joo F, Das DK, de Leiris J, Der P, Juhasz B, Varga E, Bacskay I, Balla J, Kovacs P, Tosaki A: Heme oxygenase-1-related carbon monoxide production and ventricular fibrillation in isolated ischemic/reperfused mouse myocardium. FASEB J, (2003) 17: 2133-2135 Impakt faktor: 8.817 46. Varga Z, Ujhelyi L, Kiss A, Balla J, Czompa A, Antus S. Effect of silybin on phorbol myristate actetate-induced protein kinase C translocation, NADPH oxidase activity and apoptosis in human neutrophils. Phytomedicine, (2004) 11: 206-212 Impakt faktor: 1.377 47. Lakatos B, Szentmihalyi K, Vinkler P, Balla J, Balla G. The role of essential metal ions in the human organism and their oral supplementation to the human body in deficiency states. Orv Hetil (2004) 145:1315-1319 48. Smrzova J, Balla J, Bárány P. Inflammation and resistance to erythropoiesisstimulating agents what do we know and what needs to be clarified? Nephrol Dial Transplant, (2005) 20(Suppl 8): 2-7 Impakt faktor: 2.840 49. Balla J. The issue of renal safety of zoledronic acid from a nephrologist's point of view. Oncologist, (2005) 10:306-308 Impakt faktor: 4.623 50. Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Eaton JW, Balla G. Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Mol Nutr Food Res, (2005) 49:1030-1043. Impakt faktor: 2.072 51. Vas T, Wagner Z, Jenei V, Varga Z, Kovacs T, Wittmann I, Schinzel R, Balla G, Balla J, Heidland A, Nagy J. Oxidative stress and non-enzymatic glycation in IgA nephropathy. Clin Nephrol. (2005) 64:343-351 Impakt faktor: 1,316 5

52. Varga Z, Seres I, Nagy E, Ujhelyi L, Balla G, Balla J, Antus S. Structure prerequisite for antioxidant activity of silybin in different biochemical systems in vitro. Phytomedicine. (2005) 13:85-93 Impakt faktor: 1,201 53. Szappanos H, Szigeti GP, Pal B, Rusznak Z, Szucs G, Rajnavolgyi E, Balla J, Balla G, Nagy E, Leiter E, Pocsi I, Marx F, Csernoch L. The Penicillium chrysogenum-derived antifungal peptide shows no toxic effects on mammalian cells in the intended therapeutic concentration. Naunyn Schmiedebergs Arch Pharmacol. (2005) 371:122-132 Impakt faktor: 1,963 54. Nagy E, Jeney V, Vercellotti GM, Eaton J, Yachie A, Balla G, Balla J. Oxidation of hemoglobin by lipid hydroperoxide associated with low-density lipoprotein (LDL) and increased cytotoxic effect by LDL oxidation in heme oxygenase-1 (HO-1) deficiency. Cellular and Molecular Biology, (2005) 51:377-385 Impakt faktor: 1,153 55. Szappanos H, Szigeti GP, Pal B, Rusznak Z, Szucs G, Rajnavolgyi E, Balla J, Balla G, Nagy E, Leiter E, Pocsi I, Hagen S, Meyer V, Csernoch L. The antifungal protein AFP secreted by Aspergillus giganteus does not cause detrimental effects on certain mammalian cells. Peptides. (2006) 27:1717-1725. Impakt faktor: 2,511 56. Varga Z, Paragh G, Seres I, Kakuk G, Karanyi Z, Karpati I, Matyus J, Csongradi E, Juhasz A, Balla J, Bajnok L: Hyperleptinemia is not responsible for decreased paraoxonase activity in hemodialysis patients. Nephron, (2006) 103:114-120. Impakt faktor: 1.462 57. Ujhelyi L, Balla G, Jeney V, Varga V, Nagy E, Vercellotti GM. Agarwal A, Eaton JW, Balla J. Uremic plasma ultrafiltrate inhibits oxidative modification of LDL and delays LDL oxidation provoked endothelial cell reactions. Kidney Int, (2006) 69:144-151. Impakt faktor: 5,302 58. Ujhelyi L, Balla G, Jeney V, Varga V, Nagy E, Vercellotti GM. Agarwal A, Eaton JW, Balla J. Janus-faced p-cresol retention solute inhibits oxidation of low-density lipoprotein. Kidney Int, (2006) 70:232-233. Impakt faktor: 5,302 59. Pocsi I, Miskei M, Karanyi Z, Emri T, Ayoubi P, Pusztahelyi T, Balla G, Prade RA. Comparison of gene expression signatures of diamide, H2O2 and menadione exposed Aspergillus nidulans cultures--linking genome-wide transcriptional changes to cellular physiology. BMC Genomics. (2005) 6:182-92. Impakt faktor: 4,092 6

60. Lakatos B, Balla J, Vinkler P, Szentmihalyi K. The role of macro-elements in the human body. Orv Hetil. (2006) 147(20):925-30. 61. Szentmihályi K, Vinkler P, Fodor J, Balla J, Lakatos B. The role of manganese in the human organism. Orv Hetil. (2006) 147(42):2027-30. 62. Varga Z, Seres I, Nagy E, Ujhelyi L, Balla G, Balla J, Antus S. Structure prerequisite for antioxidant activity of silybin in different biochemical systems in vitro. Phytomedicine. (2006) 13:85-93. Impakt faktor: 1,349 63. Varga Z, Paragh G, Seres I, Kakuk G, Karanyi Z, Karpati I, Matyus J, Csongradi E, Juhasz A, Balla J, Bajnok L. Hyperleptinemia is not responsible for decreased paraoxonase activity in hemodialysis patients. Nephron Clin Pract. (2006) 103:114-20. Impakt faktor: 1,440 64. Loboda A, Jazwa A, Jozkowicz A, Dorosz J, Balla J, Molema G, Dulak J. Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells. Atherosclerosis. (2006) 187:26-30. Impakt faktor: 3,777 65. Szatmari I, Vamosi G, Brazda P, Balint BL, Benko S, Szeles L, Jeney V, Ozvegy-Laczka C, Szanto A, Barta E, Balla J, Sarkadi B, Nagy L. Peroxisome proliferator-activated receptor gamma-regulated ABCG2 expression confers cytoprotection to human dendritic cells. J Biol Chem. (2006) 281(33):23812-23. Impakt faktor: 5,854 66. Balla J, Magyar MT, Bereczki D, Valikovics A, Nagy E, Barna E, Pal A, Balla G, Csiba L, Blasko G. Serum levels of platelet released CD40 ligand are increased in early onset occlusive carotid artery disease. Dis Markers. (2006) 22:133-40. Impakt faktor: 2,619 67. Pusztahelyi T, Molnár Z, Emri T, Klement E, Miskei M, Kerékgyárto J, Balla J, Pócsi I. Comparative studies of differential expression of chitinolytic enzymes encoded by chia, chib, chic and naga genes in Aspergillus nidulans. Folia Microbiol (Praha). 2006;51(6):547-54. Impakt faktor: 0,963 68. Pamplona A, Ferreira A, Balla J, Jeney V, Balla G, Epiphanio S, Chora A, Rodrigues CD, Gregoire IP, Cunha-Rodrigues M, Portugal S, Soares MP, Mota MM. Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med. (2007) 13(6):703-710. Impakt faktor: 28.878 69. Balla J, Vercellotti GM, Jeney V, Yachie A, Varga Z, Jacob HS, Eaton JW, Balla G. Heme, heme oxygenase and ferritin: how the vascular endothelium 7

survives (and dies) in an iron-rich environment. Antiox Redox Singn. (2007) 9(12):2119-37. Impakt faktor: 4.232 69. Balla J, Balla G, Lakatos B, Jeney V, Szentmihályi K. Heme-iron in the human body. Orv Hetil. (2007) 148(36):1699-706. 70. Balla J, Jeney V, Varga Z, Komódi E, Nagy E, Balla G. Iron homeostasis in chronic inflammation. Acta Physiol Hung. (2007) 94(1-2):95-106. 71. Magyar MT, Bereczki D, Csípo I, Gyimesi E, Csiba L, Valikovics A, Balla J, Sipka S. Elevated white blood cell count, CRP and fibrinogen levels are not associated with increased anti-endothelial and anti-ox-ldl antibody, MCP- 1, and RANTES levels in early onset occlusive carotid artery disease. Cytokine. (2007) 37(1):44-50. Impakt faktor: 2.355 72. Harangi M, Mátyus J, Nagy E, Nagy E, Paragh G, Balla J, Oláh AV. Identification of sulfhemoglobinemia after surgical polypectomy. Clin Toxicol (Phila). (2007) 45(2):189-92. Impakt faktor: 1.091 73. Csánky E, Asztalos L, Vaskó A, Szucs I, Dévényi K, Szilasi M, Balla J. Successful renal transplantation following lung transplantation: a survey of the first Hungarian case. Orv Hetil. (2007) 148(45):2147-51. 74. Sulowicz W, Locatelli F, Ryckelynck JP, Balla J, Csiky B, Harris K, Ehrhard P, Beyer U; PROTOS Study Investigators. Once-monthly subcutaneous C.E.R.A. maintains stable hemoglobin control in patients with chronic kidney disease on dialysis and converted directly from epoetin one to three times weekly. Clin J Am Soc Nephrol. (2007) 2(4):637-46. 75. Varga Z, Kosaras E, Komodi E, Katko M, Karpati I, Balla J, Paragh G, Aisa MC, Galli F. Effects of tocopherols and 2,2'-carboxyethyl hydroxychromans on phorbol-ester-stimulated neutrophils. J Nutr Biochem. 2007 Jul 31 Impakt faktor: 2.945 76. Fekete A, Emri T, Gyetvai A, Gazdag Z, Pesti M, Varga Z, Balla J, Cserháti C, Emody L, Gergely L, Pócsi I. Development of oxidative stress tolerance resulted in reduced ability to undergo morphologic transitions and decreased pathogenicity in a t-butylhydroperoxide-tolerant mutant of Candida albicans. FEMS Yeast Res. (2007) 7(6):834-47. Impakt faktor: 2.274 77. Mohás M, Szigeti N, Markó L, Molnár GA, Cseh J, Laczy B, Tamaskó M, Balla J, Kappelmayer J, Wagner L, Wagner Z, Csiky B, Nagy J, Wittmann I. Serum total LDH activity and LDH-2 isozyme in nephrotic syndrome. Kidney Blood Press Res. (2008) 31(1):47-54. Impakt faktor: 1.895 8

78. Mátyus J, V Oláh A, Ujhelyi L, Kárpáti I, Balla J. The epidemic of chronic kidney disease requires the estimation of glomerular filtration rate. Orv Hetil. (2008) 149(2):77-82. 79. Ferreira A, Balla J, Jeney V, Balla G, Soares MP: A central role for free heme in the pathogenesis of severe malaria: the missing link? J Mol Med 86:1097-1111, 2008. Impact factor: 5,157 80. Pócsi I, Jeney V, Kertai P, Pócsi I, Emri T, Gyémánt G, Fésüs L, Balla J, Balla G: Fungal siderophores function as protective agents of LDL oxidation and are promising anti-atherosclerotic metabolites in functional food. Mol Nutr Food Res. 52(12):1434-47, 2008. Impact factor: 3,439 81. Jeney V, Komódi E, Nagy E, Zarjou A, Vercellotti GM, Eaton JW, Balla G, Balla J : Supression of hemin-mediated oxidation of LDL and subsequent endothelial reactions by H 2 S. Last two authors contributed equally to this study stated in Free Rad Biol Medicine. 45:616-623, 2009. Impact factor: 5,440 82. Zarjou A, Jeney V, Arosio P, Poli M, Antal-Szalmás P, Agarwal A, Balla G, Balla J: Ferritin-ferroxidase activity prevents calcification and osteoblastic differentiation of vascular smooth muscle cells. Last two authors contributed equally to these studies is stated. In press. J Am Soc Nephrol. 2009. Impact factor: 7.371 Absztraktok ( idézhet_, nemzetközi kongresszusok): Cummulativ impact factor: 691,104 Citation: 3 1. Balla G, Balla J, Rosenberg M, Nath K, Jacob HS and Vercellotti GM: Sequestration of intracellular iron by ferritin: a crucial antioxidant strategem of endothelium. Clin Res, (1991) 39:724A 2. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW and Vercellotti GM: Endothelial ferritin: a crucial defense against iron-driven oxidation. Blood, (1991) 78:396A Impakt faktor: 8,782 3. Balla J, Balla G, Jacob HS, Nath K and Vercellotti GM: Endothelilal cell heme oxygenase and ferritin induction by heme proteins: dependence on heme release. Clin Res, (1992) 40:323A 9

4. Cermak J, Key NS, Bach RR, Balla J, Jacob HS and Vercellotti GM: Inflammation and thrombosis: C-reactive protein induces tissue factor synthesis in monocytes. Blood, (1992) 80:268A Impakt faktor: 8,782 5. Bok R, Jacob HS, Balla J, Juckett M, Shatos MA and Vercellotti GM: Herpes simplex virus decreases endothelial cell plasminogen activator inhibitor 1. Clin Res, (1992) 40:169A 6. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, Eaton JW and Vercellotti GM: Induction of endothelial ferritin: a cytoprotective strategem of the vessel wall. J Cell Biol, (1992) 6A: A101 Impakt faktor: 12,880 7. Cermak J, Balla J, Balla G, Jacob HS and Vercellotti GM: Iron, ferritin, and oxidant-mediated cytolysis in tumor cells: possible role in chemotherapy sensitivity. Clin Res, (1992) 40:737A 8. Nath KA, Balla J, Trick W, Cerra F and Vercellotti GM: Acut elevation in mean arterial pressure and depletion of plasma arginine induced by hemeproteins. J Am Soc Nephrology, (1992) 3:548 Impakt faktor: 6,182 9. Cermak J, Key NS, Bach RR, Balla J and Vercellotti GM: C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor: implications for thrombosis during inflammation. Clin Res, (1992) 40:715 10. Cermak J, Balla J, Balla G, Jacob HS and Vercellotti GM: Rersistance of tumor cells to free radical-mediated killing: Role of iron and ferritin. Blood, (1992) 80:435A Impakt faktor: 8,782 11. Vercellotti GM, Balla J, Balla G,Jacob HS and Eaton J: Heme and the vasculature: an oxidative hazard that induces antioxidant defenses in the endothelium. Vth International Symposium on Blood Substitutes, (1993) G7, San Diego 12. Cermak J, Balla J, Balla G, Jacob HS, Nath K and Vercellotti GM: Iron, ferritin, and oxidant-mediated cytolysis in cancer cells: possible role in chemotherapy sensitivity. IVth International Conference on Hemochromatosis and Clinical Problems in Iron Metabolism. Xith International Conference on Iron and Iron Proteins. Abstract book, (1993) 11:48, Tel Aviv, Israel 10

13. Balla J, Belcher JD, Balla G, Jacob HS and Vercellotti GM: Oxidized LDL and endothelium: Oral vitamin E supplementation prevents oxidized LDLmediated vascular injury. Clin Res, (1993) 41:191A 14. Juckett MB, Balla J, Balla G, Jacob HS and Vercellotti GM: Ferritin protects endothelial cells from oxidized low density lipoprotein mediated cytotoxicity. Clin Res, (1993) 41:191A 15. Vercellotti GM, Belcher JD, Balla J, Balla G, Juckett M and Jacob HS: Iron, lipoproteins, and endothelium: Vitamin E supplementation prolongs lag time and protects the vasculature. American Journal of Hypertension, (1993) 6:30 Impakt faktor: 2,083 16. Balla J, Vercellotti GM, Eaton JW, Jacob HS and Balla G: Heme oxygenase and ferritin induction as a protective vessel wall endothelial cell response against free radical stress. Oxygen free radicals and scavengers in the biological and medical sciences, Hungary, Abstract book A2, (1993) 17. Balla J, Vercellotti GM, Eaton JW, Jacob HS and Balla G: Heme oxygenase and ferritin induction as a protective vessel wall endothelial cell response against free radical stress. International conference on critical aspects of free radicals in chemistry, biochemistry and medicine, (1993) Vienna, Austria 18. Jucket MB, Balla J, Weber ML, Peloquin JM, Jacob HS and Vercellotti GM: S-nitroso-penicillamin modulates the induction of ferritin by iron in endothelial cells. Clin Res, (1993) 41:668A 19. Balla J, Balla G, Nath K, Jacob HS and Vercellotti GM: Methemoglobin induces heme oxygenase and ferritin in rat lungs in vivo. Clin Res, (1993) 41:685A 20. Eaton JW, Balla G, Balla J and Vercellotti GM: Heme iron and oxidative cell death. Free Radical Biology & Medicine, (1993) 15:516 Impakt faktor: 4,079 21. Belcher JD, Balla J, Balla G, Jacobs DR, Gross M, Jacob HS and Vercellotti GM: Vitamin E supplements protect LDL and vascular endothelium from oxidative injury. 66 th Scientific Sessions of the American Heart Association, (1993) 66:47, Atlanta, USA 22. Juckett MB, Balla J, Weber ML, Peloquin JM, Jacob HS and Vercellotti GM: Endothelial ferritin induction by iron is inhibited by nitric oxide generators. Blood, (1993) 82:433A Impakt faktor: 8,782 11

23. Balla J, Balla G, Vercellotti GM and Jacob HS: Heme arginate and the vasculature: Mechanism for its safety compared to hematin in porphyria. Blood, (1993) 82:283A Impakt faktor: 8,782 24. Vercellotti GM, Key NS, Bach RR, Balla J, Jacob HS and Cermak J: Induction of human monocyte tissue factor by C-reactive protein: possible role in thrombosis associated with inflammation. Thrombosis and Haemostasis, (1993) THHADQ 69(6):873 Impakt faktor: 4,983 25. Vercellotti GM, Juckett MB, Balla J, Balla G and Jacob HS: Endothelial cell ferritin protects against oxidized low-density-lipoprotein mediated cytotoxicity. Journal of Cellular Biochemistry, (1994) 18A:299 Impakt faktor: 2,817 26. Balla J, Balla G, Nath K, MB Juckett, Jacob HS and Vercellotti GM: Endothelial cell heme oxygenase and ferritin induction in rat lungs by hemoglobin in vivo. Clin Res, (1994) 42:146A 27. Jucket MB, Balla J, Weber ML, Jacob HS and Vercellotti GM: Nitric oxide blocks ferritin induction by iron and protects endothelial cells from ironmediated oxidative injury. Clin Res, (1994) 42:182A 28. Agarwal A, Balla J, Croatt AJ, Alam J and Nath KA: Induction of heme oxygenase (HO) is a protective response in acute cisplatin nephropathy (CPN). J Am Soc Nephrology, (1994) Impakt faktor: 6,182 29. Agarwal A, Balla J, Croatt AJ and Nath KA: Oxidized LDL (LDLox) injures renal tubular epithelial cells (TEC): Implications for tubulo-interstitial disease (TID). J Am Soc Nephrology, (1994) Impakt faktor: 6,182 30. Balla J, Balla G, Jacob HS, Vercellotti GM and Nath K: Heme oxygenase and ferritin induction in kidney and endothelium to prevent oxidant damage. 22 nd Congress of International Society of Internal Medicine, Abstract book, (1994) 94:225, Budapest 31. Balla J, Balla G, Kakuk G, Agarwal A and Nath KA: Endothelial cell heme oxygenase and ferritin induction by heme- and copper-catalyzed oxidation of LDL. J Invest Med, (1995) 43:376A Impakt faktor: 2,922 12

32. Balla J, Balla G, Jockob HS, Vercellotti GM and Nath K: Heme oxygenase and ferritin induction in kidney and endothelium to prevent oxidant damage. Nephrol Dial Transplant, (1995) 95:37A Impakt faktor: 1,752 33. Balla J, Balla G, Vercellotti GM and Jacob HS: Heme arginate and the vasculature. Summer Meeting of Society for Free Radical Research, (1995) Abstract book, 95:50, Budapest 34. Balla G, Balla J, Lörincz I, Jacob HS and Vercellotti GM: "Janus-faced" haem in atherogenesis: Induction of sensitization and desensitization of endothelium to oxidant damage. European Heart Journal, (1995) 16:1337 Impakt faktor: 3,210 35. Balla J, Balla G, Ujhelyi L, Kakuk G, Agarwal A, Vercellotti GM and Nath K: Heme-mediated LDL oxidation, heme oxygenase and ferritin induction in the pathogenesis of atherosclerosis and glomerulosclerosis. XXXIII congress of the European Renal Association, (1996) Abstract book, 96:69, Amsterdam 36. Balla J, Balla G, Kakuk G, Nath K, Jacob HS and Vercellotti GM: "Janusfaced" haem in atherogenesis: Induction of sensitization and desensitization of endothelium to oxidant damage. 66 th Congress of the European Atherosclerosis Society, (1996) Abstract book, Firenze, 96:58 37. Balla G, Balla J, Agarval A, Nath K, Jacob HS and Vercellotti GM: Induction of endothelial cell heme oxygenase and ferritin genes by hemeand copper- modified LDL.VIII Biennial Meeting International Society for Free Radical Research, (1996) Abstract book, 96:207, Madrid 38. Balla J, Balla G, Ujhelyi L, Kakuk G, Agarwal A, Vercellotti GM and Nath K: Heme-mediated LDL oxidation, heme oxygenase and ferritin induction in the pathogenesis of atherosclerosis and glomerulosclerosis. Nephrol Dial Transplant, (1996) 11:54A Impakt faktor: 1,752 39. Balla J, Balla G, Kakuk G, Nath K, Jacob HS and Vercellotti GM: Heme arginate and the endothelium: Mechanism for its safety in porphyria. J Invest Med, (1996) 44:214A Impakt faktor: 2,922 40. Balla J, Balla G, Kakuk G, Újhelyi L, Jacob HS, Vercellotti GM, Nath K: Heme oxygenase and ferritin induction in endothelial cells and kidney. 13 th Danube Symposium on Nephrology, (1996) Abstract book, 13:18, Cracow 41. Balla J, Balla G, Kakuk G, Ujhelyi L, Agarwal A, Jacob HS and Nath K: Upregulation of heme oxygenase and ferritin genes by heme-mediated 13

oxidation of LDL in endothelial and renal tubular epithelial cells. Nephrol Dial Transplant, (1997) 12:38A Impakt faktor: 1,752 42. Ujhelyi l, Balla J, Balla G, Vercellotti GM, Kakuk G and Jacob HS: Microassay for assessing low density lipoprotein resistance to free radical stress. Nephrology, (1997) 3:802A Impakt faktor: 0,438 43. Balla J, Balla G, Kakuk G, Ujhelyi L and Nath K: Heme oxygenase and ferritin induction by heme-mediated oxidative modification of LDL in endothelial and renal tubular epithelial cells. Nephrology, (1997) 3:801A Impakt faktor: 0,438 44. Szöke G, Balogh I, Lenkey A, Bereczki Z, Balla J and Muszbek L: Plasma total homocysteine level in maintainance haemodialysis patients. 71th International Congress on Pediatric Laboratory Medicine, (1998) Abstract book 71:48, Estovil 45. Balla J, Balla G, Kakuk G, Ujhelyi L, Nath K, Jacob HS and Vercellotti GM: Upregulation of heme oxygenase and ferritin genes by heme analogues: Sensitization and desensitization of endothelium to oxidant damage. Nephrol Dial Transplant, (1998) 13:13A Impakt faktor: 1,752 46. Balla J, Balla G, Kakuk G, Jeney V, Ujhelyi L, Nath K and Vercellotti GM: Hemoglobin induced upregulation of heme oxygenase and ferritin in rat lung and kidney in vivo to prevent oxidant damage. Nephrol Dial Transplant, (1999) 14:41A Impakt faktor: 1,752 47. Ujhelyi L, Balla J, Kakuk G, Muszbek L, Jeney V, and Balla G: Alteration of oxidative resistance of low-density lipoprotein by hemodialysis treatment. VIIIth Annual Clinical Nephrology Meetings, (1999) Abstract book, 8:45A, Washington D.C. 48. Szöke G, Balogh I, Lenkey A, Bereczki Z, Balla J and Muszbek L: Plasma total homocysteine level in maintainance haemodialysis patients of different MTHFR genotypes. 17 th International and 13 th European Congress of Clinical Chemistry and Laboratory Medicine, 1 st International Congress of Clinical Molecular Biology (IFCC World Lab), (1999) Abstract book, S 154, Firenze 49. Szöke G, Balogh I, Lenkey A, Bereczki Z, Balla J and Muszbek L: Plasma total homocysteine level in maintainance haemodialysis patients of different MTHFR genotypes. Clin Chem Lab Med, (1999) 37:S154 Impakt faktor: 1,084 50 Kárpáti I, Mátyus J, Újhelyi L, Balla J, Varga Zs, Balla J: Connection between plasma levels of ET-1, NO, and hypotonic events during 14

dialysis.xvth International Congress of Nephrology, (1999) Abstract book, S 277, Buenos Aires 51. Ujhelyi L, Balla J, Jeney V, Varga Z, Kakuk G and Balla G: Uremic metabolites protect against oxidative modification of low-density lipoprotein. Nephrol Dial Transplant, (2000) 15:166A Impakt faktor: 1,752 52. Bereczki D, Balla J, Valikovics A, Kappelmayer J, Olvasztó S, Magyar T, Fekete I, Csiba L: Degree of carotid stenosis correlates with serum homocysteine but not with cholesterol or trigliceride levels in patients below 55 years of age. Stroke, (2000) 31:2792 Impakt faktor: 5,528 53. Balla J, Balla G, Kakuk G, Jeney V, Ujhelyi L, Jacob HS and Vercellotti GM: Iron-protoporphyrin IX associated with arginate does not serve as a free radical catalyst but induces cytoprotectants in endothelial and tubular epithelial cells. Nephrol Dial Transplant, (2000) 15:19A Impakt faktor: 1,752 54. Magyar T, Valikovics A, Csiba L, Balla J, Bereczki D: Comparison of online measurements of intima-media thickness in patients with atherosclerotic carotid artery disease. Cerebrovascular diseases, (2001) 11(suppl 4):52A Impakt faktor: 1,744 55. Valikovics A, Balla J, Magyar T, Kappelmayer J, Csiba L, Bereczki D: Relationship between ultrasonographic and serum lipid parameters of young patients with occlusive disease patients with occlusive disease. Neurological Sciences, (2001) 187(suppl):22 56. Valikovics A, Balla J, Magyar T, Szikszai Z, Imres S, Csiba L, Balla G, Kappelmayer J, Bereczki D: Serum homocysteine and c-reactive protein are higher in young patients with occlusive carotid artery disease. Cerebrovascular diseases, (2002) 13(suppl 4):28A Impakt faktor: 1,744 57. Ujhelyi L, Jeney V, Dobolyi A, Varga Z, Kakuk G, Balla G, Balla J: Oxidative resistance of low-density lipoprotein is changing during hemodialysis. Nephrol Dial Transplant, (2002) 17:279A Impakt faktor: 1,752 58. Balla J: Possible role of heme oxygenase-1 and ferritin in the pathogenesis of vasculitis. 16 th Danube Symposium on Nephrology. Bled, Slovenija, Abstract book, (2002) 2002:40A 59. Bereczki D, Balla J, Magyar T, Pal A, Nagy E, Barna E, Csiba L, Blaskó G: Serum level of the soluble CD40 ligand are increased in young patients with carotid atherosclerosis. European Journal of Neurology, (2003) 10(Suppl. 1):9A Impakt faktor: 1,565 60. Marinho M, Vasilevskaya T, Tokaji L, Gregoire C, Balla J, Soares MP: Generation and characterization of on engendered form of heme oxygenase-1 15

that can enter cells spontaneously. Heme Oxygenase: Regulation, Function and Clinical Application Conference. Uppsala, Sweden, Abstract book, (2003) 2003:40 61. Balla J, Jeney V, Yachie A, Vercellotti GM, Eaton JW, Balla G: Prooxidant and antioxidant effects of circulating heme. Heme Oxygenase: Regulation, Function and Clinical Application Conference. Uppsala, Sweden, Abstract book, (2003) 2003:3 62. Szentmihályi K, Blázovics A, Újhelyi L, Balla J, Vinkler P: Antioxidant properties of magnesium compounds. Magnesium Res, (2003) 16(4):337 Impakt faktor: 0,667 63. Lakatos B, Balla J, Balla G, Szentmihályi K, Vinkler P: Magnesium homeostasis. Magnesium Res, (2003) 16(4):332-333 Impakt faktor: 0,667 64. Lakatos B, Balla J, Balla G, Szentmihályi K, Vinkler P: Role of magnesium deficiency in the prooxidant effects. Magnesium Res, (2003) 16(4):332-333 Impakt faktor: 0,667 62. Bereczki D, Csipo I, Gyimesi E, Magyar TM, Valikovics A, Balla J, Sipka S: Inflammatory markers in patients with early onset occlusive carotid artery disease. 5 th Word Stroke Congress, Geneva, Switzerland, Stroke, (2004) 35:E227 Impakt faktor: 5,233 63. Magyar T, Valikovics F, Nagy D, Barna E, Csiba L, Bereczki D, Balla J, Blaskó G: Platelet derived CD40 ligand but not soluble CD40 levels are increased in early onset occlusive carotid artery disease. 5 th Word Stroke Congress, Geneva, Switzerland, Stroke, (2004) 35:E226 Impakt faktor: 5,233 64. Balla J, Pócsi I, Jeney V, Pócsi I, Gyémánt G, Winkelmann G, Vercellotti GM, Eaton JW, Balla G: Fungal siderophores function as protective agents of LDL oxidation. Heme Oxygenase: Regulation, Function and Clinical Application Conference. Boston, USA, Abstract book, (2005) 2005:46 65. Jeney V, Nagy E, Yachie A, Szabó R, Wagner O, Vercellotti GM, Eaton JW, Balla G, Balla J: Oxidation of hemoglobin by lipid hydroperoxide associated with LDL and increased cytotoxic effect by LDL oxidation in heme oxygenase-1 deficiency. Heme Oxygenase: Regulation, Function and Clinical Application Conference. Boston, USA, Abstract book, (2005) 2005:58 Absztraktok (nem idézhet_, hazai országos kongresszusok): 1. Balla J, Balla Gy, Kakuk Gy, Jacob HS, Vercellotti GM: A Haem mediálta low density lipoprotein oxidáció és endothelialis hatásai. Magyar Nephrológiai Társaság 1995 évi Nagygyülése (Budapest), Abstract book, (1995) 1995:21 16

2. Balla J, Balla Gy, Kakuk Gy, Vercellotti GM, Jacob H, Nath K: Az intracellularis heme oxygenase és ferritin inductio kivédi az oxigéngyökök által okozott vesekárosodást. Magyar Nephrológiai Társaság 1994 évi Nagygyülése (Debrecen), Abstract book, (1994) 1994:39 3. Balla J, Jacob HS, Vercellotti GM, Balla Gy: Új aetiologia az arteriosclerosisban: Haem-Heme Oxygenase-Ferritin rendszer és az endothelium. Magyar Kardiológiai Társaság 1995 évi Nagygyülése (Balatonfüred), Abstract book, (1995) 1995:37 4. Balla J, Balla G, Kakuk G, Újhelyi L, Jacob HS, Vercellotti GM, Nath K: Heme oxygenase and ferritin induction in endothelial cells and kidney. 13 th Danube Symposium on Nephrology (Cracow), Abstract book, (1996) 13:18 5. Balla J, Balla Gy, Újhelyi L, Kakuk G, Vercellotti GM, Nath K, Jacob HS: Az arteriosclerosis új pathogenetikai tényezöje: Haem-vas mediálta vascularis sérülés. Magyar Nephrológiai Társaság 1996 évi Nagygyülése (Miskolc), Abstract book, (1996) 1996:29 6. Balla J, Balla G, Jacob HS, Vercellotti GM: Haem mediálta vascularis endothelialis károsodás, mint az atherosclerosis új pathogenetikai tényezöje. Magyar Atherosclerosis Társaság 1996 évi Nagygyülése (Sopron), Abstract book, (1996) 1996:8 7. Balla J, Balla Gy, Újhelyi L, Kakuk Gy: Haen-heme oxygenase-ferritin rendszer és az endothelium. Magyar Belgyógyász Társaság 1996 évi Nagygyülése (Budapest), Abstract book, (1996) 1996:16 8. Balla J, Kakuk Gy, Ujhelyi L, Vercellotti GM, Nath K, Balla Gy: Az LDL oxidativ modificatioja az endothelialis és mesangialis heme oxygenase gén egyek regulátora. Magyar Nephrológiai Társaság 1997 évi Nagygyülése (Pécs), Abstract book, (1997) 1997:18 9. Balla J, Ujhelyi L, Kakuk G, Balla G: Haem mediálta vascularis károsodások. Magyar Thrombosis és Haemostasis Társaság IV. Kongresszusa, (Szeged), Abstract book, (1997) 1997:1 10. Balla J, Kakuk Gy, Jeney V, Ujhelyi L, GM Vercellotti, K Nath, Balla Gy: Az LDL oxidativ modificatioja az endothelialis és tubularis heme oxygenase gén egyek regulátora. Magyar Nephrológiai Társaság 1998 évi Nagygyülése (Budapest), Abstract book, (1998) 1998:28 11. Balla J, Újhelyi L, Jeney V, Kakuk Gy, Jacob HS, Vercellotti GM, Balla Gy: Az LDL oxidatív rezisztenciájának meghatározása. Magyar Atherosclerosis Társaság 1998 évi Nagygyülése (Sopron), Abstract book, (1998) 1998:28 12. Balla J, Balla Gy, Jeney V, Ujhelyi L, Jacob HS, Vercellotti GM, Nath K, Kakuk Gy: Az endothelialis és mesangialis heme oxygenase gént az LDL oxidatív modifikációja regulálja. Magyar Belgyógyász Társaság 1998 évi Nagygyülése (Budapest), Abstract book, (1998) 1998:28 13. Balla J, Balla G, Jeney V, Kakuk G, Újhelyi L, Jacob HS, Vercellotti GM, Nath K: Heme-mediated LDL oxidation, induction of heme oxygenase and 17

ferritin in the pathogenesis of atherosclerosis and glomerulosclerosis. 14 th Danube Symposium on Nephrology (Prága), Abstract book, (198) 14:58 14. Muszbek L, Szöke G, Balogh I, Bereczky Zs, Lenkey Á, Balla J: A hyperhomocysteinaemia klinikai kémiai és molekulárgenetikai iagnosztikája. A Magyar Thrombosis és Haemostasis Társaság V. Kongresszusa (Bükfürdö), Abstract book, (1998) 5:10 15. Balla J, Balla Gy, Jeney V, Ujhelyi L, Kakuk Gy, Vercellotti GM: Az LDL oxidatív modificatioja: Az endothelialis és tubularis heme oxygenase és H- ferritin gének regelátora. Magyar Nephrológiai Társaság 1999 évi Nagygyülése (Szeged), Abstract book, (1999) 1999:28 16. Ujhelyi L, Balla G, Jeney V, Varga Zs, Kakuk Gy, Balla J: Urémiás metabolitok védenek a low-density lipoprotein (LDL) oxidatív módosulásával szemben. Magyar Nephrológiai Társaság 2000 évi Nagygyülése (Budapest), Abstract book, (2000) 2000:32 17. Balla J, Jeney V, Ujhelyi L, Varga Zs, Kakuk Gy, Vercellotti GM, Balla J: Iron-protoporphyrin IX associated with arginate does not serve as a free radical catalyst but induces cytoprotectants in endothelium and tubular epithelium. Magyar Nephrológiai Társaság 2000 évi Nagygyülése (Budapest), Abstract book, (2000) 2000:33 18. Kárpáti I, Balla J, Ben t, Ujhelyi L, Mátyus L, Varga Zs, Kakuk Gy, Bereczky Zs, Balogh I, Muszbek L: A hiperhomociszteinémia gyakorisága folsav pótlásban részesül_ hemodializált betegekben a MTHFR polimorfizmusa. Magyar Nephrológiai Társaság 2000 évi Nagygyülése (Budapest), Abstract book, (2000) 2000:35 19. L_rincz I, Szabó Z, Mátyus J, Kárpáti I, Ujhelyi L, Balla J, Kakuk Gy: A kamrai miokardium elektromos instabilitásának mérése hemodializált betegekben. Magyar Nephrológiai Társaság 2000 évi Nagygyülése (Budapest), Abstract book, (2000) 2000:61 20. Ben T, Szabó Z, Balla J, Kárpáti I, Mátyus J, Ujhelyi L, Kakuk Gy: Életmin_ség és várható élettartam felmérése m_vesekezelt betegekben. Magyar Nephrológiai Társaság 2000 évi Nagygyülése (Budapest), Abstract book, (2000) 2000:70 21. Varga Zs, Balla J, Jeney V, Kakuk Gy: A szérum proteinek és az LDL karbamilációja: a dimetilamin hatása a karbamiláció kinetikájára és az LDL oxidatív rezisztenciájára. Magyar Nephrológiai Társaság 2000 évi Nagygyülése (Budapest), Abstract book, (2000) 2000:87 22. Dombóvári J, Mátyus J, Kárpáti I, Újhelyi L, Balla J, Seres I, Papp L, Kakuk Gy, Varga Zs. A hemodialízis hatása a krónikus vesebetegek szérumának nyomelem összetételére. Magyar Nephrológiai Társaság 2000 évi Nagygyülése (Budapest), Abstract book, (2000) 2000:97 23. Kárpáti I, Mátyus J, Balla J, Ujhelyi L, Trinn Cs, Paragh Gy, Király T, Ben T, Szabó Z, Varga Zs, Kakuk Gy: Lipidcsökkent_k, rhabdomyolysis és akut veseelégtelenség. Fibrát-kezelés kiváltotta akut veseelégtelenség krónikus 18

veseelégtelenségben szenved_ betegen. Magyar Nephrológiai Társaság 2000 évi Nagygyülése (Budapest), Abstract book, (2000) 2000:120 24. Ujhelyi L, Halász O, Galajda Z, Jeney V, Varga Zs, Kakuk Gy, Balla J, Balla Gy: Oxidatív stressz szerepe a szívm_tétekhez társuló akut veseelégtelenségben. Hypertonia és Nephrologia, (2001) S3:99 25. Ben T, Szabó Z, Balla J, Kárpáti I, Mátyus J, Újhelyi L, Kakuk Gy: Életmin_ség és várható élettartam m_vesekezelt betegekben. Hypertonia és Nephrologia, (2001) S3:112 26. Szabó Z, Kakuk Gy, Fülöp T, Mátyus J, Balla J, Kárpáti I, Juhász A, Kun Cs, Karányi Zs, L_rincz I: A hemodialízis hatása a P hullám id_tartamára és diszperziójára. Hypertonia és Nephrologia, (2001) S3:121 27. Varga Zs, Mátyus J, Kárpáti I, Ujhelyi L, Balla J, Kakuk Gy: Nyomelem eltérések hemodialízis programban kezelt krónikus vesebetegekben. Hypertonia és Nephrologia, (2001) S3:92 28. Ujhelyi L, Jeney V, Dobolyi A, Varga Zs, Kakuk Gy, Balla J: Az LDL oxidatív rezisztenciája változik hemodialízis alatt. Hypertonia és Nephrologia, (2002) S4:32 29. Varga Zs, Seres I, Kárpáti I, Mátyus J, Balla J, Újhelyi L, Ben T, Kakuk Gy: Leptin és a gyulladásos citokinek HD vesebetegekben. Hypertonia és Nephrologia, (2002) S4:32 30. Ladányi E, Balla J, Kiss I, Reusz Gy: Hetei egyszeri, szubkután, biztonságos, hatékony és költség-hatékony Epo kezelés renális anaemiában neorecormon-nal. Hypertonia és Nephrologia, (2002) S4:343 31 Juhász M, Páll D, Kovács T, Zrinyi M, Balla J, Kárpáti I, Mátyus J, Ujhelyi L, Kakuk Gy: Krónikus hemodialízis kezelés során észlelt vérnyomásváltozások jellemz_i, különös tekintettel a dialízis hypotensiora. Hypertonia és Nephrologia, (2002) S4:54 32. Kovács T, Páll D, Juhász M, Zrinyi M, Balla J, Kárpáti I, Mátyus J, Ujhelyi L, Kakuk Gy: A magasvérnyomás gyógyszeres kezelésének jellemz_i hemodializált betegeknél. Hypertonia és Nephrologia, (2002) S4:54 33. Trinn Cs, Balla J, Mátyus J, Újhelyi L, Kovács J, Kakuk Gy: A haemolyticus uraemiás syndromáról. Hypertonia és Nephrologia, (2002) S4:57 34. Kárpáti I, Balla J, Mátyus J, Dombóvári J, Ujhelyi L, Ben T, Papp L, Kakuk Gy, Varga Zs: A szérum kobalt és nikkel koncentrációja és a hyperhomocysteinaemia HD betegekben. Hypertonia és Nephrologia, (2002) S4:62 35. Jenei Z, Domokos Zs, Kárpáti I, Varga Zs, Balla J, Paragh Gy, Kakuk Gy: Krónikus hemodialízis programban kezelt betegek cardiovascularis rizikótényez_inek és célszerv-károsodásainak vizsgálata. Hypertonia és Nephrologia, (2002) S4:68 36. Balla J, Kiss I: Vasanyagcsere vizsgálata dializált vesebetegeken beszámoló a nemzeti vasanyagcsere felmérés programjának aktuális állásáról. Hypertonia és Nephrologia, (2002) S4:8 19

37. Bereczki D, Balla J, Magyar T, Pál A, Nagy E, Barna E, Csiba L, Blaskó Gy: A solubilis CD40 ligand szerepe carotis atherosclerosisban. Magyar Stroke Társaság VI Nemzeti Kongresszusa: Abstract book, (2003) 2003:59 38. Szentmihályi K, Blázovics A, Balla J, Újhelyi J, Taba G, Lakatos B, Vinkler P.: Természetes eredet ligandumot tartalmazó fémvegyületek antioxidáns tulajdonságaik vizsgálata. III. MediChem Konferencia, Budapest, MTA Kémiai Kutatóközpont (2004) 39. Balla J, Magyar T, Pál A, Nagy E, Barna E, Csiba L, Blaskó Gy: A solubilis CD40 ligand szerepe carotis atherosclerosisban. Magyar Stroke Társaság VI Nemzeti Kongresszusa: Abstract book, (2003) 2003:59 40. Varga Z, Kárpáti I, Kis N, Biró S, Dombóvári J, Posta J, Újhelyi L, Mátyus J, Balla G, Papp L, Kakuk G, Paragh G, Balla J: A nikkel csökkenti a homocisztein termelést: in vivo és in vitro eredmények. Hypertonia és Nephrologia, (2005) S4:76 41. Kárpáti I, Bajnok L, Juhász A, Csongrádi É, L_rincz I, Újhelyi L, Mátyus J, Karányi Z, Paragh G, Balla J, Varga Z: A plazma nitrogén monoxid koncentróció és a vérnyomás közti kapcsolat HD betegekben. Hypertonia és Nephrologia, (2005) S4:80 42. Balla J: Vasanyagcserzavar krónikus veseelégtelenségben. Hypertonia és Nephrologia, (2005) S4:109 Egyéb absztraktok (nem idézhet_, hazai regionális vagy helyi kongresszusok, illetve szimpóziumok): El_adások száma 160 Könyvfejezetek: 1. Olah VA, Balla G, Balla J, Szabolcs A and Karmazsin L: In vitro investigation of hydroxyl-scavenging effect of Cavinton. Radicals, Ions and Tissue Damage (Ed: Matkovics B), Budapest (1990), Akadémiai Kiadó, pp:191-197 2. Balla J, Vercellotti GM, Eaton JW, Jacob HS and Balla G: Heme oxygenase and ferritin induction as a protective vessel wall endothelial cell response against free radical stress. Oxygen Free Radicals and Scavengers in the Natural Sciences (Eds: Mózsik Gy, Emerit I, Fehér J, Matkovics B, Vincze Á), Budapest (1993), Akademiai Kiado, pp: 123-126 3. Balla J, Vercellotti GM, Nath KA, Eaton JW, Belcher JD, Jacob HS and Balla G: Role of heme, heme oxygenase and ferritin in free radical mediated vascular endothelial injury. Free Radicals in the Environment, Medicine and 20

Toxicology: Critical Aspects and Current Highlights.(Eds: Nohl H, Esterbauer H, Rice-Evans C), London (1994), The Richelieu Press, Free Radical Series VIII, pp: 429-468 4. Jacob HS, Balla G, Balla J and Vercellotti GM: Heme uptake by endothelium: An oxidant damaging "Trojan horse" tamed by ferritin synthesis. The pulmonary vasculature, Chapter 11, (Eds: Weir EK, Archer SL, Reeves JT), New York (1996), Futura Publishing Co., pp: 167-177 5. Balla J: Haem mediált acut veseelégtelenség rhabdomyolysisben Nephrologiai Ismeretek, (Ed: Kakuk Gy, Kárpát I), Debrecen (1998), PP:185-196 6. Balla J: Sepsis és a vese. NephrologiaiIsmeretek, (Ed: Kakuk Gy, Kárpáti I), Debrecen (1999), PP:195-196 7. Balla J: Profilozott haemodialysis. Nephrologiai Ismeretek, (Ed: Kakuk Gy, Kárpát I), Debrecen (1999) PP:267-278 8. Balla J: Az atherosclerosis pathogenezise. Nephrologiai Ismeretek, (Ed: Kakuk Gy, Kárpát I), Debrecen (2000), PP:83-87 9. Balla J: Renalis anaemia és hyperparathyreosis kezelése. Klinikai Nephrológia, Ed: Kakuk Gy, Budapest (2004), Medicina, PP:839-855 10. Balla J: Adaequat dialízis. Klinikai Nephrológia, Ed: Kakuk Gy, Budapest (2004), Medicina, PP: 830-839 11. Balla J: Balkán nephropathia. Klinikai Nephrológia, Ed: Kakuk Gy, Budapest (2004), Medicina, PP:440-444 12. Balla J: Irradiatios nephritis. Klinikai Nephrológia, Ed: Kakuk Gy, Budapest (2004), Medicina, PP:426-429 13. Balla J: Nem steroid gyulladáscsökkent_k és a vese. Klinikai Nephrológia, Ed: Kakuk Gy, Budapest (2004), Medicina, PP:421-426 14. Balla J, Balla G. Iron homeostasis in chronic inflammation. Nephrology, Hypertension, Dialysis, Transplantation. TE Adreoli, E Ritz, L Rosivall (ed). Budapest (2006), Medicina, PP:81-92. 15. Balla J, Vercellotti GM, Jeney V, Yachie A, Nagy E, Eaton JW, Balla G. Heme, heme oxygenase and ferritin in vascular endothelial cell injury. Heme oxygenase: The elegant orchestration of its products in medicine. Leo Otterbein (ed). Boston (2005), Nova Science. PP:351-375. 16. Varga Zs, Nagy E, Katko M, Jeney V, Ujhely L, Seres I, Paragh Gy, Balla J, Antus S. Relationship of structure and antioxidant activity of synthetic silybin- and isosilybin derived melecules. New developments in antioxidants research. Harold V. Panglossi (ed). New York (2006), Nova Science. PP: 113-151. 21